Cost-effectiveness análisis ofmicro-dystrophin: a novel gene therapy for duchenne muscular dystrophy
| dc.contributor.author | Antolin Fontes, Beatriz | |
| dc.date.accessioned | 2020-11-17T16:06:10Z | |
| dc.date.available | 2020-11-17T16:06:10Z | |
| dc.date.issued | 2020 | |
| dc.description | Màster Universitari en Economia de la Salud i del Medicament. (UPF Barcelona School of Management) Curs 2017-2020 | ca |
| dc.description | Mentor: Aníbal García | |
| dc.format.mimetype | application/pdf | * |
| dc.identifier.uri | http://hdl.handle.net/10230/45788 | |
| dc.language.iso | eng | ca |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License | ca |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | ca |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | ca |
| dc.title | Cost-effectiveness análisis ofmicro-dystrophin: a novel gene therapy for duchenne muscular dystrophy | ca |
| dc.type | info:eu-repo/semantics/masterThesis | ca |
License
